Close
Contact

Unveiling MRD: Trends in Usage and Market Sentiments

As advancements in molecular and genetic technologies continue to revolutionize cancer care, MRD testing has emerged as a powerful tool for assessing treatment response, predicting disease recurrence, and guiding personalized therapeutic strategies.

For this report, we surveyed and spoke to 20 experts covering 6/10 top pharma. We also leveraged the Beacon Biomarker Database, to explore exploring the latest trends, insights, and market sentiments shaping MRD adoption and integration into clinical practice.

Do you have a future market research project that you’d like to discuss with us?

Contact

Recommended

Customer Care

Inside Intelligence

Address: 52 Grosvenor Gardens, London, SW1W 0AU.
Tel: +44 (0)20 3141 8700

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

Enabling growth is at the heart of what we do.

© Hanson Wade 2024. Hanson Wade Limited is registered in England & Wales, number 06752216. Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.